Logo image of CYTH

CYCLO THERAPEUTICS INC (CYTH) Stock Analyst Ratings

NASDAQ:CYTH - Nasdaq - US23254X2018 - Common Stock - Currency: USD

0.7206  +0.01 (+1.39%)

After market: 0.7199 0 (-0.1%)

Buy % Consensus

78

ChartMill assigns a Buy % Consensus number of 78% to CYTH. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 0.97. This target is 34.47% above the current price.
CYTH was analyzed by 9 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about CYTH.
In the previous month the buy percentage consensus was at a similar level.
CYTH was analyzed by 9 analysts. More opinions would make the average more meaningful.
CYTH Historical Analyst RatingsCYTH Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -57 -52 -47 -42 -37 -32 -27 -22 -17 -12 -7 -2 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 0.720.960.970.971.00 - 33.15% 34.47% 34.47% 38.43%
CYTH Current Analyst RatingCYTH Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2024-08-27 Maxim Group Downgrade Buy -> Hold
2024-08-26 Ascendiant Capital Maintains Buy -> Buy
2024-08-23 HC Wainwright & Co. Downgrade Buy -> Neutral
2024-08-16 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-31 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-01 HC Wainwright & Co. Initiate Buy
2024-04-22 Ascendiant Capital Initiate Buy
2023-09-27 Maxim Group Upgrade Hold -> Buy
2023-03-21 Maxim Group Downgrade Buy -> Hold